Apomorphine Subcutaneous and Dextromethorphan and phenylephrine
Determining the interaction of Apomorphine Subcutaneous and Dextromethorphan and phenylephrine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using apomorphine together with dextromethorphan may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Central nervous system (CNS) depressant effects may be additively or synergistically increased in patients using apomorphine in combination with other drugs that can also cause these effects. Apomorphine alone has been frequently associated with somnolence and dizziness. Patients may suddenly fall asleep during activities of daily living.
MANAGEMENT: The use of other sedating drugs should generally be avoided during apomorphine treatment. Patients prescribed these agents concurrently should be monitored for potentially excessive or prolonged CNS depression, especially if they are elderly or debilitated. Ambulatory patients should be made aware of the possibility of additive CNS effects (e.g., drowsiness, dizziness, lightheadedness, confusion) and counseled to avoid activities requiring mental alertness until they know how these agents affect them. If patients experience increased episodes of falling asleep during normal daily activities, they should avoid driving and other potentially hazardous activities until they have contacted their physician.
- "Product Information. Apokyn (apomorphine)." Mylan Pharmaceuticals Inc, Morgantown, WV.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: dextromethorphan / phenylephrine
Brand name: Children's Triacting Daytime, PediaCare Children's Multi-Symptom Cold, Safetussin CD, Sudafed PE Children's Cold & Cough, Triaminic Day Time Cold & Cough, Vicks Formula 44 D Cough
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Subcutaneous-Dextromethorphan and Phenylephrine Liquid
- Apomorphine Subcutaneous-Dextromethorphan and Phenylephrine Orally Disintegrating Strips
- Apomorphine Subcutaneous-Dextromethorphan and promethazine
- Apomorphine Subcutaneous-Dextromethorphan and Promethazine Syrup
- Apomorphine Subcutaneous-Dextromethorphan and Pyrilamine
- Apomorphine Subcutaneous-Dextromethorphan and quinidine
- Dextromethorphan and phenylephrine-Apra
- Dextromethorphan and phenylephrine-Apraclonidine
- Dextromethorphan and phenylephrine-Apraclonidine Hydrochloride
- Dextromethorphan and phenylephrine-Apraclonidine ophthalmic
- Dextromethorphan and phenylephrine-Apremilast
- Dextromethorphan and phenylephrine-Aprepitant